Juvenile idiopathic arthritis (TMJ involvement)

Juvenile idiopathic arthritis (JIA) is a chronic autoimmune inflammatory arthropathy of the synovial lining that begins before age 16 and persists for more than six weeks.[1][2] The temporomandibular joint (TMJ) is one of the most commonly affected joints, with involvement reported in approximately 30%–60% of patients across JIA subtypes.[3][4] Synovial inflammation (synovitis) drives the pathologic process: untreated, it progresses to synovial hyperplasia and pannus formation, which erodes articular cartilage and subchondral bone.[1] Because the mandibular condyle houses the primary growth center of the mandible, inflammatory damage in the growing child can impair mandibular growth, producing characteristic dentofacial deformity with retrognathia and facial asymmetry.[5][6] The signature radiographic pattern is condylar flattening, surface erosion, and shortening of the ramus–condyle unit, often bilateral.[3][7] Management requires interdisciplinary collaboration among rheumatology, radiology, orthodontics, and oral and maxillofacial surgery, with the goal of early suppression of inflammation and orthopedic correction of growth disturbance.[8][9]

• Juvenile idiopathic arthritis (JIA) is the current umbrella term adopted by the International League of Associations for Rheumatology (ILAR) for all forms of inflammatory arthritis of unknown cause beginning before age 16 and lasting more than six weeks.[2][10]
• The ILAR classification recognizes seven subtypes: oligoarticular, rheumatoid factor (RF)–negative polyarticular, RF-positive polyarticular, systemic-onset, enthesitis-related, psoriatic, and undifferentiated.[10]
• Older terms—juvenile rheumatoid arthritis (American usage) and juvenile chronic arthritis (European usage)—are obsolete but still encountered in legacy literature.
• When the TMJ is the focus, the condition is often specified as JIA with TMJ involvement or TMJ arthritis in JIA; the alias "juvenile idiopathic osteoarthritis" is occasionally used but is imprecise, as the primary process is inflammatory rather than degenerative.

• JIA affects approximately 0.6–1.9 per 1,000 children in high-income countries, with girls affected more often than boys (overall ratio ~3:2).[1][2]
• TMJ involvement occurs across all ILAR subtypes. A population-based Nordic cohort documented a cumulative incidence of TMJ involvement of 30.1% from disease onset to transition into adult care. Long-term CBCT follow-up of the same cohort found condylar deformities and/or erosions in 61% of participants at a mean of 17 years after disease onset, with bilateral changes in approximately 70% of those affected.[3][4]

Symptoms and presentation

TMJ arthritis in JIA is frequently clinically silent in its early stages; one study found that 71% of patients with active TMJ synovitis on MRI were asymptomatic and 63% had normal physical examination findings.[11] When symptoms develop, they commonly include:

• TMJ pain (spontaneous or on palpation)
• Morning stiffness of the jaw
• Limitation of mouth opening (reduced maximal incisal opening)
• Difficulty chewing
• TMJ crepitations, which are associated with established condylar deformity[12]

Examination findings

• Reduced maximal unassisted mouth opening is significantly associated with radiographic TMJ deformity.[3][12]
• Masticatory muscle tenderness on palpation is common but is not predictive of structural TMJ deformity.[12]
• TMJ clicking during function is more characteristic of idiopathic condylar resorption than of JIA.[13]

Dentofacial deformity

Untreated or inadequately controlled TMJ arthritis in the growing child can produce:

• Mandibular retrognathia and micrognathia
• Facial asymmetry (when involvement is unilateral or asymmetric)
• Anterior open bite
• Steepened occlusal plane
• Malocclusion with asymmetric loading[5][14]

Initial radiological signs of dentofacial deformity are subtle, characterized by minor mandibular asymmetry and occlusal plane steepening.[5]

Location and distribution

• The TMJ condyle is the primary site of radiographic change. Involvement is commonly bilateral, observed in approximately 70% of affected patients in long-term cohorts.[3]
• Unilateral involvement occurs in a minority and may produce asymmetric mandibular growth.[5][12]

Periphery and shape of the condyle

• Condylar flattening (loss of the normal convex articular surface) is the most characteristic and common osseous finding, strongly associated with initial dentofacial deformity (OR 8.42).[5][7]
• Condylar deviation in form — alteration of the overall condylar morphology from its expected rounded or ovoid shape — is the finding most strongly associated with arthritis-induced dentofacial deformity (OR 25.39).[5]
• In advanced disease, the condyle may appear markedly reduced in size or irregularly contoured.

Surface erosion

• Condylar surface erosion — focal cortical discontinuity or irregularity of the articular surface — is a common finding and one of the most prevalent imaging signs across both CBCT and MRI studies.[5][7]
• Erosion is strongly associated with initial dentofacial deformity (OR 5.38).[5]
• Erosive changes may also involve the glenoid fossa and articular eminence in more advanced cases.[15]

Internal architecture

• Subcortical cysts (subchondral radiolucencies) within the condylar head are a characteristic finding, significantly associated with dentofacial deformity (OR 5.94).[5]
• In advanced disease, generalized loss of condylar volume with trabecular rarefaction may be observed.

Effects on adjacent structures

• Shortening of the ramus–condyle unit (RCU) results from impaired condylar growth and is detectable on panoramic radiography and CBCT. A short RCU contributes to retrognathia and reduced posterior facial height.[6][16]
• Accentuated antegonial notching of the inferior mandibular border is a recognized panoramic finding; the combination of abnormal condyle morphology and accentuated antegonial notching on panoramic radiography is significantly correlated with TMJ synovitis on MRI (OR 7.5).[16]
• Glenoid fossa remodeling, including flattening or erosion of the articular eminence, may accompany condylar changes.[15]

Growth pattern and dentofacial effects

• Mandibular asymmetry and steepening of the occlusal plane are the earliest radiographic signs of arthritis-induced dentofacial deformity.[5]
• Progressive retrognathia, reduced posterior-to-anterior lower facial height ratio, and anterior open bite develop with continued growth impairment.[13]

Panoramic radiography

• Panoramic radiographs may reveal abnormal condylar morphology, short RCU, and accentuated antegonial notching, but are often normal at disease onset and have limited sensitivity for early inflammatory changes.[1][16]
• Panoramic findings should prompt further evaluation with cross-sectional imaging when JIA is suspected.[1]

Cortical bone detail on CBCT

• CBCT provides superior visualization of cortical erosions, subcortical cysts, and condylar morphology compared to panoramic radiography.[12][17]
• CBCT-detected deformities may be present even in TMJs considered clinically "healthy," underscoring the discrepancy between clinical and radiographic findings.[5][15]
• Both progressing and improving TMJ deformities have been documented on serial CBCT over two-year follow-up, reflecting the dynamic nature of the disease.[12]

Variants and late findings

• Ankylosis — fibrous or bony fusion of the TMJ — is a rare but recognized late complication of severe, untreated disease.[14]
• Heterotopic bone formation within the joint space has been reported, occasionally as a complication of intra-articular corticosteroid injection.[9]

MRI

Contrast-enhanced MRI is the reference standard for diagnosing and monitoring TMJ arthritis in JIA, as it visualizes both soft-tissue inflammation and osteochondral damage.[1][6]

• Acute/active findings: Joint effusion, synovial thickening with enhancement on post-gadolinium sequences, and bone marrow edema within the condyle are the hallmarks of active inflammation. Post-contrast images should be acquired promptly, as gadolinium diffuses rapidly into the joint space and can obscure synovial enhancement.[1][6][18]
• Chronic findings: Condylar flattening, surface erosions, disc abnormalities (flattening or deformity rather than anterior displacement), and shortening of the mandibular ramus. Disc flattening is significantly more common in JIA than in non-JIA causes of TMJ destruction, whereas anterior disc displacement is characteristic of idiopathic condylar resorption.[6][18][19]
• Validated semiquantitative scoring systems (OMERACT JIA MRI and EuroTMjoint) allow standardized grading of inflammation and damage for treatment monitoring.[18]

Ultrasound

Ultrasound can detect synovial thickening, increased capsular–condylar distance, and power Doppler hypervascularity, offering a radiation-free, sedation-free screening tool.[17][20] However, it cannot assess bone marrow edema or the deepest portions of the joint, and no accepted scoring system exists for TMJ ultrasound in JIA.[20]

TMJ condylar erosion and remodeling in a pediatric or adolescent patient raises a focused differential. The clinical context — particularly the presence or absence of systemic inflammatory disease, age, sex, and disc position — guides differentiation.

The highest-risk diagnostic pitfall is failing to distinguish JIA from idiopathic condylar resorption, as both present with progressive condylar destruction in young patients and inflammatory and osseous MRI findings overlap substantially; disc morphology (flattened in JIA vs. anteriorly displaced in ICR) and a thorough rheumatologic workup are the most reliable discriminators.[13][19]

Synovial biopsy of the TMJ is rarely performed for diagnosis but reveals findings paralleling those of rheumatoid arthritis in adults. The hallmark is synovial hyperplasia with expansion of the lining layer, infiltration by lymphocytes (CD4+ and CD8+ T cells, B cells), macrophages, and plasma cells.[1][22] Two broad histopathologic patterns have been described: an inflammatory/adaptive immune pattern with M1-like macrophage–rich lining, prominent CD8+ T cell infiltration, and greater lining hypertrophy; and an M2-like macrophage–predominant pattern with thinner lining.[22]

Pannus tissue — hypertrophic synovium composed of activated fibroblast-like synoviocytes and macrophages — invades and degrades articular fibrocartilage and subchondral bone through release of matrix metalloproteinases (MMPs), driven primarily by TNF-α and IL-1β.[1][23][24] RANKL-mediated osteoclastogenesis contributes to subchondral bone resorption.[23] Unlike most diarthrodial joints, the TMJ condyle is covered by fibrocartilage rather than hyaline cartilage, and the secondary cartilage growth center lies immediately beneath the articular surface, making it uniquely vulnerable to inflammatory destruction and growth impairment.[11]

Radiologic–pathologic correlation: condylar surface erosions correspond to sites of pannus invasion through the fibrocartilage; subcortical cysts reflect focal subchondral bone resorption; and condylar flattening represents the cumulative effect of cartilage and bone loss with attempted reparative remodeling.

Systemic pharmacotherapy

The 2021 American College of Rheumatology (ACR) guideline recommends treatment of TMJ arthritis regardless of the presence of clinical symptoms, given its destructive potential.[9]

• NSAIDs: A trial of scheduled NSAIDs is conditionally recommended as initial therapy, though the trial should be brief due to limited efficacy.[9]
• Intra-articular glucocorticoids (IAGCs): Conditionally recommended for active TMJ arthritis. No preferred corticosteroid formulation is specified for the TMJ. IAGCs should be used sparingly, preferably in skeletally mature patients, because of TMJ-specific risks including heterotopic ossification and impaired condylar growth. A meta-analysis reported pain resolution in 78% and a mean gain in mouth opening of 4.4 mm following IACS injection.[9][25]
• Conventional synthetic DMARDs: Strongly recommended for inadequate response to NSAIDs and/or IAGCs; methotrexate is conditionally preferred over leflunomide.[9]
• Biologic DMARDs: Conditionally recommended for inadequate response to at least one conventional DMARD; no preferred biologic agent is specified. Rapid escalation to biologics (potentially combined with conventional DMARDs) is often appropriate given the destructive nature of TMJ arthritis.[9]

Orthopedic and orthodontic management

Interdisciplinary consensus recommendations emphasize early initiation of orthopedic treatment with occlusal splints or functional appliances to redirect mandibular growth and correct developing dentofacial deformity.[5][8] Physiotherapy and jaw exercises may improve mouth opening and reduce symptoms.[26]

Surgical correction

Orthognathic surgery is indicated for stable, skeletally mature patients with established dentofacial deformity and quiescent disease.[27] Mandibular distraction osteogenesis, alone or combined with Le Fort I osteotomy and/or bilateral sagittal split osteotomy, achieves durable improvement in mandibular advancement, facial height, and occlusal relationships.[28][29] Alloplastic TMJ reconstruction is reserved for severe cases but should be used cautiously in skeletally immature patients.[27]

Prognosis and surveillance

TMJ damage persists into adulthood: at 17-year follow-up, 33% of a population-based JIA cohort reported orofacial symptoms and 61% had condylar deformities on CBCT.[3] Interdisciplinary follow-up extending into adult care is recommended.[3][8] Early diagnosis and prompt anti-inflammatory treatment remain the strongest determinants of favorable long-term outcome.[5][9]

Pediatric growth considerations

The TMJ condyle is the principal mandibular growth center, covered only by a thin layer of fibrocartilage. Inflammatory damage during active growth produces irreversible dentofacial deformity — retrognathia, micrognathia, and facial asymmetry — that may not become clinically apparent until growth is well advanced.[5][11] Radiographic signs of TMJ deformity may be present in joints considered clinically healthy, supporting routine imaging surveillance in all children with JIA.[5][8]

Screening and monitoring recommendations

Interdisciplinary consensus recommendations advise that all children diagnosed with JIA undergo orofacial evaluation, including imaging, regardless of TMJ symptoms.[8] Contrast-enhanced MRI is the modality of choice for detecting active inflammation; CBCT is complementary for assessing osseous deformity and monitoring structural change over time.[1][17] The ACR Appropriateness Criteria rate MRI TMJ with and without IV contrast as the most appropriate initial imaging study when TMJ arthritis is suspected.[1]

This article synthesizes current evidence from the 2021 ACR treatment guideline, interdisciplinary consensus recommendations, ACR Appropriateness Criteria, systematic reviews of imaging findings, population-based cohort studies, and foundational radiologic and clinical research.[1][3][4][5][6][7][8][9][11][16][17][18][19][26] Key points supported by the evidence include:

• The cumulative incidence of TMJ involvement (30.1%) and long-term condylar deformity prevalence (61%) are drawn from the Nordic JIA population-based cohort.[3][4]
• Radiographic feature associations (condylar flattening OR 8.42, deviation in form OR 25.39, erosion OR 5.38, subcortical cyst OR 5.94) derive from a study of 96 JIA patients with matched controls.[5]
• The panoramic radiograph–synovitis correlation (OR 7.5 for combined abnormal condyle morphology and antegonial notching) comes from a study correlating panoramic findings with MRI-confirmed synovitis.[16]
• The disc morphology discriminator between JIA and idiopathic condylar resorption (flattening vs. anterior displacement) is based on a blinded MRI comparison study.[19]
• Pharmacotherapy recommendations follow the 2021 ACR guideline, which provides the most current evidence-based framework for TMJ arthritis treatment in JIA.[9]